|
Post by audiomr on Oct 10, 2017 3:47:53 GMT -5
Just because they are doctors doesn't imply intelligence. Most have good memorization abilities, but little deep thinking skills. I'm not real good with statistics, but remember reading that something like 50% of all doctors graduated in the lower half of their class. Seems like a lot, but I can believe it. In case you're not joking: By definition, 50% of any class must graduate in the lower half, as the lower half is the lower 50%.
|
|
|
Post by anderson on Oct 10, 2017 5:56:38 GMT -5
I'm not real good with statistics, but remember reading that something like 50% of all doctors graduated in the lower half of their class. Seems like a lot, but I can believe it. In case you're not joking: By definition, 50% of any class must graduate in the lower half, as the lower half is the lower 50%. What if there is an odd number of students, wouldnt you round up, 50 in upper and 49 in lower. Technically that would be only 49.4949494949....%(which would round to 49%) in the lower half.
|
|
|
Post by sportsrancho on Oct 10, 2017 5:59:03 GMT -5
Is she willing to call MNKD and have some reps come out? Yes. She would prefer a MNKD rep to contact her via LinkedIn to set something up. I’ll try to figure out how to send you a private message with her contact info. They are on it:-)
|
|
|
Post by promann on Oct 10, 2017 6:10:17 GMT -5
Yes. She would prefer a MNKD rep to contact her via LinkedIn to set something up. I’ll try to figure out how to send you a private message with her contact info. They are on it:-) Sports your the best. Bocagirl please let us know how your doctor friend feels about Afrezza after her meeting with the MNKD reps. This is all wonderful thank you both for helping to bring awareness. 😄👏
|
|
|
Post by victoria on Oct 10, 2017 7:21:56 GMT -5
In case you're not joking: By definition, 50% of any class must graduate in the lower half, as the lower half is the lower 50%. What if there is an odd number of students, wouldnt you round up, 50 in upper and 49 in lower. Technically that would be only 49.4949494949....%(which would round to 49%) in the lower half. no, I think they use the leftover student for dissection classes so they get an exact figure. Or thats what I heard anyhow...😁
|
|
|
Post by straightly on Oct 10, 2017 8:52:21 GMT -5
What if there is an odd number of students, wouldnt you round up, 50 in upper and 49 in lower. Technically that would be only 49.4949494949....%(which would round to 49%) in the lower half. no, I think they use the leftover student for dissection classes so they get an exact figure. Or thats what I heard anyhow...😁 I literally heard that only in Minnesota (or was it the twin city?) every kid is above average, every woman is strong and every man beautifual.
|
|
|
Post by mnholdem on Oct 10, 2017 10:18:55 GMT -5
You almost nailed the Garrison Keillor quote from Prairie Home Companion.
"Welcome to Lake Wobegon (Minnesota), where all the women are strong, all the men are good-looking, and all the children are above average."
|
|
|
Post by victoria on Oct 10, 2017 10:47:25 GMT -5
You almost nailed the Garrison Keillor quote from Prairie Home Companion.
"Welcome to Lake Wobegon (Minnesota), where all the women are strong, all the men are good-looking, and all the children are above average."
I love that place, great fan of GK. I expect in lake Wobegon every doctor prescribes afrezza too... Idyllic sigh...
|
|
|
Post by boca1girl on Oct 14, 2017 8:36:47 GMT -5
Sports your the best. Bocagirl please let us know how your doctor friend feels about Afrezza after her meeting with the MNKD reps. This is all wonderful thank you both for helping to bring awareness. 😄👏 Update: MNKD rep has contacted my doctor friend, requesting a time to meet. I will provide an update after the meeting takes place.
|
|
|
Post by LosingMyBullishness on Oct 14, 2017 11:48:39 GMT -5
I spoke to a doctor friend on Saturday who had prescribed Afrezza to two patients over a year ago. She works at a federally funded clinic and the patients no longer go there. She was under the impression that Afrezza was off the market when SNY discontinued it and has not prescribed it since. When I told her MNKD was selling it and they just received fda approval of the enhanced label, she was surprised. What makes matters worse is that she is now pre-diabetic and sees nothing wrong with taking Metformin. Education of the doctor population is EXTREMEMLY important if Afrezza is to exceed! Some additional comments: This doctor friend is now 60 and WAS willing to try Afrezza for her patients two years ago. She was informed that the product was being discontinued, as SNY was not marketing it any longer, therefore she didn’t prescribe again. This doctor has a very large patient load at her clinic so I don’t blame her after being told the product was no longer available from SNY. Education/awareness is EXTREMELY important along with better insurance coverage. I do not get it. She was informed that it was discontinued? So the SNY guy told this doctor that SNY discontinues it ,although the SNY guy knew that it is continued by MNKD? That is not what was agreed upon to my knowledge. And the medic did not factchecked this statement although he had two patients on that drug. Hmm. Not very committed. Sorry this is not meant to be rude to this person. It is just sad that sometimes people are so superficial.
|
|
|
Post by sportsrancho on Oct 14, 2017 12:46:07 GMT -5
Some additional comments: This doctor friend is now 60 and WAS willing to try Afrezza for her patients two years ago. She was informed that the product was being discontinued, as SNY was not marketing it any longer, therefore she didn’t prescribe again. This doctor has a very large patient load at her clinic so I don’t blame her after being told the product was no longer available from SNY. Education/awareness is EXTREMELY important along with better insurance coverage. I do not get it. She was informed that it was discontinued? So the SNY guy told this doctor that SNY discontinues it ,although the SNY guy knew that it is continued by MNKD? That is not what was agreed upon to my knowledge. And the medic did not factchecked this statement although he had two patients on that drug. Hmm. Not very committed. Sorry this is not meant to be rude to this person. It is just sad that sometimes people are so superficial. I can understand your point of view but I know for a fact that is what some of the SNY reps were saying. I also know doctors that stopped prescribing because they thought we were going under and did not want to put a patient on a drug and then have to pull them off it down the road. They felt it would make them look stupid.
|
|
|
Post by brotherm1 on Oct 14, 2017 12:57:50 GMT -5
Yes, a friend of mine is a nurse at the Penn State Hershey Med Center. When SNY had it she was told SNY said Afrezza was being discontinued. .
|
|
|
Post by curiousdoc on Oct 14, 2017 13:42:03 GMT -5
The fault here is that some on this board think all primary care doctors are diabetes experts that have read about a fringe drug (Yes, afrezza is a fringe drug) as much those who are invested it have. They actually go to school/train for a minimum of 11 years, but who's counting?
The label change is helpful, but there is still very little peer-reviewed accepted research to change established care guidelines. Could Afrezza be an excellent supplement to or replace some care regimens? Probably. But anecdotal success and company claims are not going to change the minds of physicians who have been taught every step of the way to "practice evidence based medicine."
Education is vitally important, but even with education it will take TIME for attitudes to change. Probably best to target younger doctors who are not set in their ways after decades of practice.
For what its worth I recently talked to one colleague (<5 years out of residency) who was having such success with GLP1 drugs he didn't see the need to try another drug with less evidence behind it. Although, he was open to trying Afrezza.
Pipe dream with our cash situation but we need studies showing A1C improvements in uncontrolled patients; for example poorly controlled Type2 patients that should be on insulin but were reluctant to start or couldn't be trusted to avoid Hypoglycemic events.
|
|
|
Post by boca1girl on Oct 14, 2017 16:51:15 GMT -5
Some additional comments: This doctor friend is now 60 and WAS willing to try Afrezza for her patients two years ago. She was informed that the product was being discontinued, as SNY was not marketing it any longer, therefore she didn’t prescribe again. This doctor has a very large patient load at her clinic so I don’t blame her after being told the product was no longer available from SNY. Education/awareness is EXTREMELY important along with better insurance coverage. I do not get it. She was informed that it was discontinued? So the SNY guy told this doctor that SNY discontinues it ,although the SNY guy knew that it is continued by MNKD? That is not what was agreed upon to my knowledge. And the medic did not factchecked this statement although he had two patients on that drug. Hmm. Not very committed. Sorry this is not meant to be rude to this person. It is just sad that sometimes people are so superficial. I don’t mean to be rude, but you didn’t read my post. She no longer sees the two patients she prescribed for. I don’t know how long they remained patients after she prescribed or what success they had with Afrezza. Yes, believe it or not, she was informed that SNY was discontinuing the drug and SNY gave no further information. (There is a strong rumor on this board that SNY didn’t want Afrezza to succeed, if you can believe that.) She is a very dedicated primary care physician with a heavy case load, not an endo, but was willing to give Afrezza a try. Maybe if you were in her place, you would have doubted the SNY rep when he/she reported that Afrezza was being discontinued. But guess what, when I told her that Afrezza was still available, she agreed to meet with a MNKD rep in the near future. She is not superficial but I think you maybe naieve about things work in the real world.
|
|
|
Post by figglebird on Oct 14, 2017 17:18:37 GMT -5
Let me assure the poster of this topic that whatever one alleges Snys conduct as being w respect to their partnershipobligations as laid out in both the supply and primary agreement - they settled w mannkind on what at the time were financial terms that enabled the company to survive - terms that we're not stipulated in the agreement.
there is no need nor point rettrying what had already been settled.
Snys alleged misconduct = loan forgiveness and insulin purchase.
Hence the profitable year.
Hence the future viability - lights still on.
|
|